APP Pharmaceuticals Launches Rocuronium Bromide Injection (Business Wire via Yahoo! Finance) |
![]() |
SCHAUMBURG, Ill.----APP Pharmaceuticals, Inc., a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has launched Rocuronium Bromide Injection, the generic equivalent of Organon’s Zemuron®. |